Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Testicular Neoplasms × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Ifosfamide 8 Carboplatin 7 Paclitaxel 5 Filgrastim 5 Etoposide 5 Dexamethasone 3 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Ondansetron 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Calcium Dobesilate 2 Aprepitant 2 tremelimumab 1 thymoglobulin 1 poly ICLC 1 pembrolizumab 1 palifosfamide lysine 1 palbociclib 1 isophosphamide mustard 1 fosaprepitant 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 dehydroftorafur 1 cytokine inducible SH2-containing protein 1 alvocidib 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡